Evaluating Pediatric Endovascular Thrombectomy in High-Risk Cardiac Cases

Pediatric acute ischemic stroke is a devastating emergency that causes severe long-term neurological disability in young patients. Cardiac abnormalities represent one of the most common predisposing risk factors, accounting for nearly one-third of pediatric stroke presentations globally. Consequently, managing large vessel occlusion in children requires prompt, specialized intervention to salvage brain tissue. Historically, pediatric endovascular thrombectomy faced clinical uncertainty and therapeutic hesitation, especially in children with underlying cardiac disease. Clinicians frequently feared procedural complications, difficult vascular access, altered systemic hemodynamics, and heightened hemorrhagic risk during intervention. However, emerging prospective evidence from multinational stroke registries demonstrates that mechanical thrombectomy offers substantial therapeutic benefits in young populations. Evaluating clinical outcomes across cardiac subgroups is therefore essential for refining pediatric stroke protocols. Prospective registry data now confirm that endovascular intervention improves functional recovery without compromising safety, even in high-risk cardiac cases.

Methodology of the Save ChildS Pro Multinational Study

To determine if cardiac disease alters endovascular effectiveness, researchers conducted a secondary analysis of the prospective Save ChildS Pro registry. This prospective multinational study enrolled pediatric stroke patients across international tertiary centers between 2018 and 2023, tracking 90-day functional follow-up outcomes. Eligible participants included children aged 28 days to 18 years presenting with confirmed large vessel occlusion stroke. Additionally, complete 90-day Pediatric Stroke Outcome Measure scores were required for inclusion. Cardiac abnormalities were defined as congenital or acquired structural heart defects documented by echocardiography or verified medical records. Among 178 analyzed patients, 56 children (31.5 percent) had documented cardiac disease. The primary study endpoint focused on poor functional outcome at 90 days, defined as a Pediatric Stroke Outcome Measure score above 0.5. Secondary endpoints evaluated modified Rankin Scale shift analyses and longitudinal Pediatric NIH Stroke Scale recovery trajectories over time.

Functional Outcomes Across Cardiac and Non-Cardiac Groups

The observational results yielded essential clinical insights regarding treatment allocation and procedural efficacy in young patients. Notably, children with underlying cardiac abnormalities received pediatric endovascular thrombectomy significantly more frequently than non-cardiac patients. This clinical pattern reflects the higher initial stroke severity and embolic burden typical of cardioembolic stroke presentations. Crucially, multivariate regression revealed that cardiac abnormality status was not independently associated with adverse functional outcomes (odds ratio 0.93; 95% CI, 0.36–2.52). Furthermore, researchers found no significant statistical interaction between endovascular treatment and cardiac abnormality status. This crucial finding confirms that the therapeutic benefit of mechanical thrombectomy remains consistent regardless of underlying cardiac disease. Consequently, therapeutic hesitation based solely on a cardiac history is clinically unwarranted, as both patient cohorts achieve comparable neurological recovery following successful endovascular vessel recanalization.

Accelerated Neurologic Recovery and Procedural Safety Profile

Secondary outcome analyses further established the strong clinical efficacy of mechanical thrombectomy in pediatric stroke care. Ordinal modified Rankin Scale shift analysis and longitudinal stroke scale modeling demonstrated accelerated neurological recovery trajectories following mechanical revascularization. Children receiving thrombectomy achieved rapid functional gains compared to those managed with conservative medical therapy alone. Importantly, procedural safety endpoints remained highly favorable across all analyzed patient subgroups. Overall adverse event rates did not differ between thrombectomy and medical therapy groups, regardless of cardiac abnormality status. Complications such as groin access site injuries or symptomatic intracranial hemorrhages remained remarkably low. Therefore, the study provides Class IV clinical evidence that endovascular therapy safely improves 90-day functional outcomes in pediatric acute ischemic stroke, irrespective of underlying cardiac condition status.

Overcoming Clinical Hesitation in High-Risk Pediatric Patients

Pediatric stroke care frequently suffers from diagnostic delays and conservative treatment hesitation among healthcare providers. Clinicians evaluating children with cardiac disease often express concern over femoral arterial catheterization safety, altered systemic hemodynamics, or radiological contrast exposure. However, evidence from the Save ChildS Pro registry challenges these clinical reservations directly. Because endovascular treatment provides robust functional recovery without elevating adverse event rates, underlying cardiac status should not preclude mechanical intervention. Multidisciplinary emergency teams must streamline diagnostic pathways and neurointerventional workflows. Pediatric cardiologists, neurointerventionalists, stroke neurologists, and intensivists should collaborate during hyperacute evaluations to manage systemic parameters effectively while proceeding with revascularization. Advances in pediatric-sized microcatheters further enhance procedural safety, ensuring young patients with cardioembolic strokes receive equitable, life-saving care.

Future Directions in Pediatric Stroke Management

While registry data provide reassuring guidance, ongoing research remains critical to refining pediatric neurointerventional care systems globally. Prospective international registries are essential because randomized controlled trials in pediatric stroke remain logistically challenging due to small patient volumes. Future investigations should examine long-term cognitive outcomes and establish standardized perioperative anticoagulation protocols for children with congenital heart defects. Additionally, medical education targeting pediatric emergency clinicians should emphasize rapid stroke symptom recognition, particularly in children with known cardiac disease. Implementing emergency magnetic resonance or computed tomography angiography protocols will minimize door-to-recanalization times significantly. Ultimately, incorporating endovascular thrombectomy into routine pediatric stroke guidelines will overcome therapeutic hesitation, offering young patients optimal opportunities for complete functional recovery and long-term independence.

Frequently Asked Questions

Is endovascular thrombectomy safe for children with underlying heart disease?

Yes, endovascular thrombectomy is safe for children with underlying cardiac disease. Recent multinational registry data show that adverse event rates, including access site complications and symptomatic hemorrhage, do not differ significantly between cardiac and non-cardiac pediatric stroke patients undergoing mechanical revascularization procedures.

How does underlying cardiac disease affect pediatric stroke outcomes after thrombectomy?

Underlying cardiac abnormalities do not independently worsen functional outcomes or impair neurological recovery after mechanical thrombectomy. Pediatric stroke patients with cardiac defects experience accelerated neurological recovery and improved 90-day functional outcomes similar to children without heart conditions when treated with timely endovascular intervention.

Why are children with cardiac abnormalities at higher risk for acute ischemic stroke?

Children with congenital or acquired cardiac disease have an increased risk of stroke due to altered hemodynamics, structural heart defects, implanted prosthetic materials, or arrhythmia formation. These underlying cardiovascular conditions can promote thrombus development, which subsequently embolizes into the cerebral circulation, causing acute large vessel occlusions.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Healthcare professionals should rely on their professional clinical judgment and refer to official guidelines when making treatment decisions.

References

1. Dmytriw AA et al. Functional Outcomes and Safety of Endovascular Thrombectomy in Pediatric Acute Ischemic Stroke With Cardiac Abnormalities. Neurology. 2026 Aug 11. doi: 10.1212/WNL.0000000000218270. PMID: 42479995.


2. Sporns PB et al. Endovascular thrombectomy for childhood stroke (Save ChildS Pro): an international, multicentre, prospective registry study. Lancet Neurol. 2024;23(1):45-56.


3. Bhatia KD et al. Association Between Thrombectomy and Functional Outcomes in Pediatric Patients With Acute Ischemic Stroke From Large Vessel Occlusion. JAMA Neurol. 2023;80(9):910-918.